A Study of CYB004 in Participants with Generalized Anxiety Disorder (GAD)

OPENING SOON

Study Sponsored by Cybin IRL Limited 

A Phase 2a, Randomized, Double-Blind, Active-Controlled Study to Assess the Preliminary Clinical Efficacy, Safety, Tolerability, and Pharmacokinetics, of CYB004 (N-dimethyltryptamine (DMT) Analog) in Participants with Generalized Anxiety Disorder (GAD)

Learn More

To learn about other open trials click the button below:

View Open Clinical Trials